Enzyme Replacement Slowed Progression Of Complications Of Fabry Disease
Sat, 23 Dec 2006 12:00 PM EST
... Agalsidease-beta therapy for Fabry disease slowed progression of kidney, heart and nervous system complications and death compared to placebo, a new study found. Fabry disease is a hereditary disease in which a faulty gene causes inadequate metabolism of certain fats in the body. [click link for full article] ...
Related Topics
- Enzyme Therapy
- Hip Replacement
- Lyme Disease
- Fabry disease
- Pregnancy Complications
- Fabry's Disease
- Hormone Replacement Therapy
- Hormone Therapy
- Diseases & Conditions
- Knee
- Heart Disease
- Bone Disease
- Lung Diseases & Disorders
- Huntington's Disease
- Kidney Disease
- Rare Diseases
- Crohn's Disease
- Graves' Disease
- Autoimmune Diseases
- Periodontal Disease

Not Signed In -


